• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

比利时金黄色葡萄球菌流行欧洲夫西地酸耐药性脓疱疮克隆(EEFIC)的持续存在。

Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.

机构信息

Department of Microbiology, LHUB-ULB, National Reference Centre for Staphylococcus aureus and other species, Université libre de Bruxelles, route de Lennik 808, 1070 Brussels, Belgium.

Centre for Environmental Health and Occupational Health, Public Health School, Université libre de Bruxelles, route de Lennik 808, 1070 Brussels, Belgium.

出版信息

J Antimicrob Chemother. 2023 Aug 2;78(8):2061-2065. doi: 10.1093/jac/dkad204.

DOI:10.1093/jac/dkad204
PMID:37358399
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10393872/
Abstract

OBJECTIVES

In August 2018, a public health alert was issued in Belgium regarding clusters of impetigo cases caused by the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus. As a result, the Belgian national reference centre (NRC) was commissioned to update the epidemiology of S. aureus causing community-onset skin and soft tissues infection (CO-SSTI) to assess the proportion of EEFIC among them.

METHODS

For 1 year, Belgian clinical laboratories were asked to send their first three S. aureus isolated from CO-SSTI each month. Isolates were tested for antimicrobial susceptibility to oxacillin, mupirocin and fusidic acid. Resistant isolates were also spa typed and tested for the presence of the genes encoding the Panton-Valentine leucocidin, the toxic shock syndrome toxin and the exfoliatins A and B. MLST clonal complexes were deduced from the spa types.

RESULTS

Among the 518 S. aureus strains analysed, 487 (94.0%) were susceptible to oxacillin. Of these, 79 (16.2%) were resistant to fusidic acid, of which 38 (48.1%) belonged to the EEFIC. EEFIC isolates were mostly isolated from young patients with impetigo and showed a seasonal late summer peak.

CONCLUSIONS

These results suggest the persistence of EEFIC in Belgium. Furthermore, its prevalence may lead to reconsideration of the treatment guidelines for impetigo.

摘要

目的

2018 年 8 月,比利时发布了一项公共卫生警报,称金黄色葡萄球菌引起的脓疱疮疫情欧洲耐药性脓疱疮克隆(EEFIC)出现了多起病例。因此,比利时国家参考中心(NRC)受委托更新金黄色葡萄球菌引起社区获得性皮肤和软组织感染(CO-SSTI)的流行病学情况,以评估其中 EEFIC 的比例。

方法

在一年的时间里,比利时临床实验室被要求每月将其首次从 CO-SSTI 中分离出的前三种金黄色葡萄球菌菌株送交到 NRC。对分离株进行药敏试验,检测对苯唑西林、莫匹罗星和夫西地酸的耐药性。耐药分离株还进行 spa 型分析,并检测编码杀白细胞素、毒性休克综合征毒素和表皮剥脱素 A 和 B 的基因的存在情况。MLST 克隆复合体由 spa 型推断得出。

结果

在分析的 518 株金黄色葡萄球菌中,487 株(94.0%)对苯唑西林敏感。其中,79 株(16.2%)对夫西地酸耐药,其中 38 株(48.1%)属于 EEFIC。EEFIC 分离株主要从脓疱疮的年轻患者中分离出来,且具有夏季末的季节性高峰。

结论

这些结果表明 EEFIC 在比利时仍然存在。此外,其流行率可能需要重新考虑脓疱疮的治疗指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38f/10393872/0baeb11a3ff2/dkad204f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38f/10393872/0baeb11a3ff2/dkad204f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d38f/10393872/0baeb11a3ff2/dkad204f1.jpg

相似文献

1
Persistence of the Staphylococcus aureus epidemic European fusidic acid-resistant impetigo clone (EEFIC) in Belgium.比利时金黄色葡萄球菌流行欧洲夫西地酸耐药性脓疱疮克隆(EEFIC)的持续存在。
J Antimicrob Chemother. 2023 Aug 2;78(8):2061-2065. doi: 10.1093/jac/dkad204.
2
Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of , Belgium, 2013 to 2023.2013 年至 2023 年期间,比利时出现并传播了一种对莫匹罗星耐药的、具有欧洲流行的夫西地酸耐药性脓疱疮克隆的变体。
Euro Surveill. 2024 May;29(19). doi: 10.2807/1560-7917.ES.2024.29.19.2300668.
3
Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.荷兰南部普通科患者中流行的欧洲夫西地酸耐药性脓疱疮克隆(EEFIC)。
J Antimicrob Chemother. 2012 May;67(5):1176-80. doi: 10.1093/jac/dkr590. Epub 2012 Jan 30.
4
The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.由欧洲流行的耐夫西地酸脓疱病克隆株引起的脓疱病流行的下降:来自挪威西部一个社区的基于人群的11.5年发病率研究。
Scand J Infect Dis. 2014 Dec;46(12):832-7. doi: 10.3109/00365548.2014.947317. Epub 2014 Sep 17.
5
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.耐夫西地酸金黄色葡萄球菌流行欧洲克隆株引起的脓疱病的特征分析
J Clin Microbiol. 2007 May;45(5):1505-10. doi: 10.1128/JCM.01984-06. Epub 2007 Mar 7.
6
Emergence of a Staphylococcus aureus Clone Resistant to Mupirocin and Fusidic Acid Carrying Exotoxin Genes and Causing Mainly Skin Infections.出现一株对莫匹罗星和夫西地酸耐药、携带外毒素基因且主要引起皮肤感染的金黄色葡萄球菌克隆株。
J Clin Microbiol. 2017 Aug;55(8):2529-2537. doi: 10.1128/JCM.00406-17. Epub 2017 Jun 7.
7
Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.法国存在金黄色葡萄球菌的流行欧洲耐夫西地酸脓疱病克隆株(EEFIC)
J Antimicrob Chemother. 2009 Feb;63(2):420-1; author reply 421. doi: 10.1093/jac/dkn456. Epub 2008 Nov 1.
8
Impetigo in a population over 8.5 years: incidence, fusidic acid resistance and molecular characteristics.8 岁半以上人群脓疱疮:发病率、夫西地酸耐药性及分子特征。
J Antimicrob Chemother. 2011 Jun;66(6):1360-4. doi: 10.1093/jac/dkr102. Epub 2011 Mar 9.
9
An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant with additional resistance to fusidic acid, June 2018 to January 2020.荷兰一起不常见的疫情爆发:2018 年 6 月至 2020 年 1 月,社区获得性脓疱疮由耐甲氧西林金黄色葡萄球菌引起,且对夫西地酸有额外耐药性。
Euro Surveill. 2022 Dec;27(49). doi: 10.2807/1560-7917.ES.2022.27.49.2200245.
10
A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway.一种与大疱性脓疱疮相关的耐夫西地酸金黄色葡萄球菌克隆正在挪威传播。
J Antimicrob Chemother. 2002 Dec;50(6):873-6. doi: 10.1093/jac/dkf217.

引用本文的文献

1
Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant ST121, Europe, 2014 to 2024.2014年至2024年,欧洲耐夫西地酸和甲氧西林的ST121型FAR-MRSA克隆的传播情况。
Euro Surveill. 2025 Jul;30(28). doi: 10.2807/1560-7917.ES.2025.30.28.2500452.
2
Clinical Features and Antibiotic Susceptibility of -Infected Dermatoses.- 感染性皮肤病的临床特征及抗生素敏感性
J Clin Med. 2025 Feb 8;14(4):1084. doi: 10.3390/jcm14041084.
3
Antimicrobial Evaluation of Two Polycyclic Polyprenylated Acylphloroglucinol Compounds: PPAP23 and PPAP53.

本文引用的文献

1
An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant with additional resistance to fusidic acid, June 2018 to January 2020.荷兰一起不常见的疫情爆发:2018 年 6 月至 2020 年 1 月,社区获得性脓疱疮由耐甲氧西林金黄色葡萄球菌引起,且对夫西地酸有额外耐药性。
Euro Surveill. 2022 Dec;27(49). doi: 10.2807/1560-7917.ES.2022.27.49.2200245.
2
Feasibility Study for a Randomised Controlled Trial for the Topical Treatment of Impetigo in Australian General Practice.澳大利亚全科医疗中脓疱疮局部治疗随机对照试验的可行性研究。
Trop Med Infect Dis. 2021 Nov 9;6(4):197. doi: 10.3390/tropicalmed6040197.
3
两种多环聚戊烯基酰基间苯三酚化合物(PPAP23 和 PPAP53)的抗菌评价。
Int J Mol Sci. 2024 Jul 23;25(15):8023. doi: 10.3390/ijms25158023.
4
Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of , Belgium, 2013 to 2023.2013 年至 2023 年期间,比利时出现并传播了一种对莫匹罗星耐药的、具有欧洲流行的夫西地酸耐药性脓疱疮克隆的变体。
Euro Surveill. 2024 May;29(19). doi: 10.2807/1560-7917.ES.2024.29.19.2300668.
The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway.
由欧洲流行的耐夫西地酸脓疱病克隆株引起的脓疱病流行的下降:来自挪威西部一个社区的基于人群的11.5年发病率研究。
Scand J Infect Dis. 2014 Dec;46(12):832-7. doi: 10.3109/00365548.2014.947317. Epub 2014 Sep 17.
4
[Home oxygen therapy. Assessment report. April 2012. Short text. Working group of the National Commission for Evaluating Medical Devices and Technologies (CNEDiMTS) of the Haute Autorité de Santé].[家庭氧疗。评估报告。2012年4月。简短文本。法国卫生高级管理局医疗设备与技术评估国家委员会(CNEDiMTS)工作组]
Rev Mal Respir. 2012 Nov;29(9):1174-8. doi: 10.1016/j.rmr.2012.09.015. Epub 2012 Oct 25.
5
Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands.荷兰南部普通科患者中流行的欧洲夫西地酸耐药性脓疱疮克隆(EEFIC)。
J Antimicrob Chemother. 2012 May;67(5):1176-80. doi: 10.1093/jac/dkr590. Epub 2012 Jan 30.
6
Interventions for impetigo.脓疱病的干预措施。
Cochrane Database Syst Rev. 2012 Jan 18;1(1):CD003261. doi: 10.1002/14651858.CD003261.pub3.
7
spa typing for epidemiological surveillance of Staphylococcus aureus.用于金黄色葡萄球菌流行病学监测的spa分型
Methods Mol Biol. 2009;551:189-202. doi: 10.1007/978-1-60327-999-4_15.
8
Presence of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) of Staphylococcus aureus in France.法国存在金黄色葡萄球菌的流行欧洲耐夫西地酸脓疱病克隆株(EEFIC)
J Antimicrob Chemother. 2009 Feb;63(2):420-1; author reply 421. doi: 10.1093/jac/dkn456. Epub 2008 Nov 1.
9
Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.瑞他帕林:用于治疗脓疱病及其他非复杂性浅表皮肤感染的综述
Drugs. 2008;68(6):855-73. doi: 10.2165/00003495-200868060-00008.
10
Characterization of the epidemic European fusidic acid-resistant impetigo clone of Staphylococcus aureus.耐夫西地酸金黄色葡萄球菌流行欧洲克隆株引起的脓疱病的特征分析
J Clin Microbiol. 2007 May;45(5):1505-10. doi: 10.1128/JCM.01984-06. Epub 2007 Mar 7.